Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M18.9Revenue (TTM) $M--Net Margin (%)--Altman Z-Score-276.0
Enterprise Value $M20.4EPS (TTM) $-1.5Operating Margin %--Piotroski F-Score3
P/E(ttm)--Beneish M-Score-63.9Pre-tax Margin (%)--Higher ROA y-yN
Price/Book--10-y EBITDA Growth Rate %-24.5Quick Ratio0.1Cash flow > EarningsY
Price/Sales--5-y EBITDA Growth Rate %-7.3Current Ratio0.1Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-534.1Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)--Less Shares Outstanding y-yY
Payout Ratio %--Shares Outstanding M11.4ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with ECTE

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
ECTECharles Brandes 2015-09-30 Sold Out $1.39 - $1.8
($1.59)
$ 1.664%Sold Out0
ECTECharles Brandes 2015-03-31 Buy $1.48 - $2.95
($2.34)
$ 1.66-29%New holding34,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

ECTE is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


ECTE: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
SCHOENBART ALAN WAYNECFO AND SECRETARY 2015-05-20Buy2,500$1.4420.83view
Hollander Scott WaynePRESIDENT AND CEO 2015-05-20Buy8,000$1.4817.57view
Nordlicht Mark10% Owner 2014-06-30Buy65,739$2.2-20.91view
Nordlicht Mark10% Owner 2014-06-26Buy17,300$2.2-20.91view
Nordlicht Mark10% Owner 2014-06-24Buy16,961$2.2-20.91view
GOLDBERG MICHAEL M 2014-02-28Sell0$0-20.91view
Nordlicht Mark10% Owner 2013-12-10Buy69,569$2.75-36.73view
Platinum Partners Value Arbitr10% Owner 2013-07-11Sell0$0-36.73view
Doman Robert FDirector 2013-03-22Buy1,500$8-78.25view
GRIECO WILLIAMDirector 2013-03-21Buy3,000$7.6-77.11view

Quarterly/Annual Reports about ECTE:

News about ECTE:

Articles On GuruFocus.com
5 Healthcare Picks for 2012 Mar 21 2012 

More From Other Websites
Echo Therapeutics Announces New Patent for its Non-Invasive Sensing Technology Jun 23 2016
Echo Therapeutics Gets Fresh Patent For Non-Invasive Sensing Technology Jun 22 2016
Echo Therapeutics Announces New Patent for its Non-Invasive Sensing Technology Jun 22 2016
Echo Therapeutics Announces Institutional Review Board (IRB) Approval of New Protocol Jun 15 2016
Echo Therapeutics Announces Institutional Review Board (IRB) Approval of New Protocol Jun 13 2016
ECHO THERAPEUTICS, INC. Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in... Jun 03 2016
Echo Therapeutics in Final Stage of Clinical Research Organization (CRO) Selection Jun 02 2016
Echo Therapeutics Says It's In Final Stage Of Clinical Research Organization Selection Jun 02 2016
Echo Therapeutics in Final Stage of Clinical Research Organization (CRO) Selection Jun 02 2016
ECHO THERAPEUTICS, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders May 26 2016
ECHO THERAPEUTICS, INC. Financials May 26 2016
Echo Therapeutics, Inc. Announces First Quarter 2016 Financial Results May 21 2016
Echo Therapeutics, Inc. Announces First Quarter 2016 Financial Results May 20 2016
ECHO THERAPEUTICS, INC. Files SEC form 10-Q, Quarterly Report May 20 2016
Echo Therapeutics Announces Successful Software Transfer to its Strategic Partner, MTIA May 17 2016
Echo Therapeutics Announces Final Closing of Private Placement of $5.1 Million of Convertible Notes... May 17 2016
Echo Therapeutics Announces Successful Software Transfer to its Strategic Partner, MTIA May 17 2016
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces the Commencement of an Investigation into... May 06 2016
Echo Therapeutics Announces Final Closing of Private Placement of $5.1 Million of Convertible Notes... May 04 2016
ECHO THERAPEUTICS, INC. Files SEC form 8-K, Creation of a Direct Financial Obligation or an... May 04 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)